U.S. market Closed. Opens in 1 day 2 hours 58 minutes

TMBR | Timber Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312020-01-312019-01-31
Revenue83.18K295.74K453.81K324.65K57.00K
Cost of Revenue13.30M6.15M1.50M3.38M83.00K
Gross Profit-13.22M-5.85M-1.05M-3.06M-26.00K
Operating Expenses19.24M10.95M18.71M586.72K16.48M
Selling, General & Admin6.02M5.39M4.06M586.56K7.40M
Research & Development13.30M6.15M15.10M3.38M9.08M
Other Operating Expenses-83.18K-590.79K-453.81KN/AN/A
Operating Income-19.24M-10.65M-20.21M-3.64M-17.23M
Other Expenses / Income-136.45K-19.17K5.13M-156.00-750.00K
Before Tax Income-19.37M-10.67M-15.08M-3.64M-17.26M
Income Tax Expenses7.60K-30.24K37.84K-156.002.00K
Net Income-19.38M-10.64M-15.12M-3.69M-17.26M
Interest Expenses228.46K15.55K4.42MN/A28.00K
Basic Shares Outstanding2.11M808.81K314.00K125.91K12.88K
Diluted Shares Outstanding2.11M808.81K314.00K125.91K12.88K
EBITDA-19.16M-10.38M-17.78M-45.56K-17.17M
EBITDA Margin-23,032.75%-3,508.96%-3,917.31%-14.03%-30,115.79%
EBIT-19.14M-10.65M-10.66M-3.69M-17.23M
EBIT Margin-23,015.25%-3,602.46%-2,349.67%-1,136.71%-30,224.56%
Financial Year End2022-12-312021-12-312020-12-312020-01-312019-01-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙